1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Bronchitis Treatment Market, by Type
6.1. Introduction
6.2. Acute Bronchitis
6.3. Chronic Bronchitis

7. Bronchitis Treatment Market, by Treatment
7.1. Introduction
7.2. Drugs
7.3. Oxygen Therapy

8. Bronchitis Treatment Market, by Class of Drugs
8.1. Introduction
8.2. Anti-inflammatory Drugs
8.3. Antibiotics
8.4. Bronchodilator
8.5. Others

9. Bronchitis Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Others
9.5. Retail Pharmacies

10. California Bronchitis Treatment Market

11. Florida Bronchitis Treatment Market

12. Illinois Bronchitis Treatment Market

13. New York Bronchitis Treatment Market

14. Ohio Bronchitis Treatment Market

15. Pennsylvania Bronchitis Treatment Market

16. Texas Bronchitis Treatment Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. American Well Corporation
18.2. AstraZeneca PLC
18.3. Boehringer Ingelheim International GmbH
18.4. Cigna Corporation
18.5. Dr. Reddy's Laboratories Ltd
18.6. F. Hoffmann-La Roche Ltd.
18.7. GlaxoSmithKline Pharmaceuticals Limited
18.8. Johnson & Johnson Services, Inc
18.9. Mayo Foundation for Medical Education and Research (MFMER)
18.10. Melinta Therapeutics, Inc.
18.11. Novartis International AG
18.12. Pfizer Inc.
18.13. Reckitt Benckiser Group PLC
18.14. Sanofi S.A
18.15. TelaCare Health Solutions, LLC

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES BRONCHITIS TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BRONCHITIS TREATMENT MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2027
FIGURE 6. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (%)
FIGURE 11. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2027 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2027
FIGURE 13. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2020 VS 2027 (%)
FIGURE 18. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2020 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2027
FIGURE 20. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 29. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 31. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 39. UNITED STATES BRONCHITIS TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 40. UNITED STATES BRONCHITIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 41. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES BRONCHITIS TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES BRONCHITIS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES BRONCHITIS TREATMENT MARKET: SCORES
TABLE 20. UNITED STATES BRONCHITIS TREATMENT MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES BRONCHITIS TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES BRONCHITIS TREATMENT MARKET: RANKING
TABLE 23. UNITED STATES BRONCHITIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES BRONCHITIS TREATMENT MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES BRONCHITIS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES BRONCHITIS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES BRONCHITIS TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES BRONCHITIS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES BRONCHITIS TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

American Well Corporation
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Cigna Corporation
Dr. Reddy's Laboratories Ltd
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Pharmaceuticals Limited
Johnson & Johnson Services, Inc
Mayo Foundation for Medical Education and Research (MFMER)
Melinta Therapeutics, Inc.
Novartis International AG
Pfizer Inc.
Reckitt Benckiser Group PLC
Sanofi S.A
TelaCare Health Solutions, LLC